This study investigates the mechanism by which transmyocardial drilling revascularization combined with heparinized basic fibroblast growth factor incorporated degradable stent implantation (TMDRSI) 
Introduction

Although bone marrow mesenchymal stem cells (BMSCs) implantation has emerged as a promising treatment for ischemic heart disease for their potential effects to improve myocardial function
and reverse ventricular remodelling [1] [2] [3] [4] , experimental and clinical studies also yielded some negative results [5] [6] [7] . It was speculated that the effect of cell transplantation may be largely impacted by the hostile microenvironment of the ischemic region [8, 9] .
In our previous report [10] ,
we have described a novel method for myocardial revascularization, i.e. transmyocardial drilling revascularization (TMDR) combined with heparinized basic fibroblast growth factor (bFGF)-incorporated degradable tubular stent implantation (TMDRSI). Our preliminary results showed that, for a miniswine model of acute myocardial ischemia, this new method, combined with Flk1
ϩ CD34 -CD31 -BMSCs transplantation, enhanced angiogenesis and myocardial perfusion, and promoted cardiac function more effectively than single approaches [11] . To explore the underlying mechanism, the present study was set to assess the following parameters, which included differentiation and paracrine function of transplanted cells, cell proliferation and apoptosis, and myocardial remodelling.
Material and methods
Miniswine experiment was approved by Tianjin Administrative Committee for Laboratory Animals. Animal care and experimental procedures were carried out strictly in compliance with the Guide for the care and use of laboratory animals published by the National Institutes of Health in 1996.
Preparation of autologous Flk1
؉ CD34 ؊ CD31 ؊
BMSCs, immunophenotyping analysis and in vitro labelling
Autologous BMSCs were isolated as described by our previous report [11] . 
Briefly, bone marrow aspirated from the anterior iliac crest was diluted with heparinized phosphate-buffered saline (PBS)
.
Surgical procedure
Miniswine (25-30 kg) were anesthetized as described previously [10] . (Fig. 2E ).
RT-PCR analysis
Identification of transplanted cells
Inhibited cell apoptosis in TSC group
As shown in Figure 3, (Fig. 3E) . Fig. 4E ).
Enhancement of myocardial viability in TSC group
Identification of the transplanted cells
We (Fig. 5A to C) , but also smooth muscle cell-specific actin (Fig. 5D to F) and musclespecific marker cTnT (Fig. 5G to J) . In C group, however, only differentiation into endothelial cells was found. In contrast, Fig. 6C ). Similar results were obtained for ESV. (Fig. 6D) 
Fig. 1 Expressions of GAPDH, vWF, VEGF, IL-1␤ and TGF-␤3 mRNA. (A) shows representative photos of electrophoresis. Qualitative analysis was performed by BandScan 5.0 software. The ratios of vWF, VEGF, IL-1␤ and TGF-␤3 to GAPDH were compared in (B-E), respectively. *P
Attenuated myocardial remodelling and improved left ventricular function in TSC group
No differences in EDV, ESV and local left ventricular wall thickness were found among the four groups prior to the treatment. Six weeks after treatment, no difference was found in local left
Discussion
Our study has demonstrated for the first time that TMDRSI can enhance the survival and differentiation of transplanted BMSCs, promoted paracrine function of such cells on repair of acute myocardial ischemia, and therefore can enable BMSCs transplantation to further attenuate myocardial remodelling at least for the subacute period.
Although BMSCs transplantation has provided a promising therapeutic option for patients with myocardial ischemia [9] , no consensus was reached as to whether such therapy may bring protective effects at clinical trials. Some authors [1] [2] [3] reported [12] [13] [14] . Recently, Rota et al. [13] 
Fig. 5 Distribution and differentiation of transplanted cells. (A), (D) and (G) showed red fluorescence-positive cells distributing around the stent in the TSC group (100ϫ magnification). (B) is the photograph of vWF staining. (C) is the merged picture of (A) and (B), revealing that survived transplanted cells were factor vWF ϩ (arrow). (E) shows stained smooth muscle actin. (F) is the merged picture of (D) and (E), suggesting differentiation into smooth muscle cells from transplanted BMSCs (arrow). (H) and (I) are cTNT and DAPI stained picture. (J) is the merged picture of (G), (H) and (I), indicating differentiation from transplanted BMSCs into cardiomyocytes and a structural integration between resident and neonatal myocytes (arrow
